345 results
8-K
EX-99.1
INSM
Insmed Incorporated
8 Aug 24
Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update
7:00am
in the conference call by dialing (888) 210-2654 (U.S.) and (646) 960-0278 (international) and referencing access code 7862189. The call will also be webcast … September 7, 2024, by dialing (800) 770-2030 (U.S.) and (609) 800-9909 (international) and referencing access code 7862189. A webcast of the call
8-K
EX-99.2
INSM
Insmed Incorporated
3 Jul 24
Regulation FD Disclosure
9:00am
; and inability to repay the Company's existing indebtedness and uncertainties with respect to the Company's need and ability to access future capital
8-K
EX-99.1
swvix fzm77knhab
3 Jul 24
Regulation FD Disclosure
9:00am
8-K
EX-99.1
2dg0apdll0u
4 Jun 24
Regulation FD Disclosure
7:00am
8-K
EX-99.2
68171
30 May 24
Insmed Announces Proposed $500 Million Public Offering of Common Stock
5:32pm
8-K
EX-99.2
2ddqvos45y2vu5hg vf
30 May 24
Insmed Announces Proposed $500 Million Public Offering of Common Stock
5:32pm
8-K
EX-1.1
pvn4d
30 May 24
Insmed Announces Proposed $500 Million Public Offering of Common Stock
5:32pm
424B5
xtcgi zoe9o4vc
30 May 24
Prospectus supplement for primary offering
4:02pm
424B5
zwk1ramj
28 May 24
Prospectus supplement for primary offering
7:14pm
8-K
EX-99.2
kf9qsg2
28 May 24
Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
6:30am
8-K
kzt12f6 8vhth
28 May 24
Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
6:30am
8-K
EX-99.1
eowq57m87u sk
28 May 24
Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis
6:30am
8-K
EX-99.1
cm1v0w71yi7d 04r
9 May 24
Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
7:05am
8-K
EX-10.1
ugenqai8d
22 Feb 24
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:58am
8-K
EX-99.1
8hos58uqbgiug
22 Feb 24
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:58am